2021
DOI: 10.1016/j.celrep.2021.109206
|View full text |Cite
|
Sign up to set email alerts
|

Molecular basis of CD-NTase nucleotide selection in CBASS anti-phage defense

Abstract: Highlights d Structural analysis of the cAAG cyclic trinucleotide synthase E. cloacae CdnD d Thermostable, pre-reactive complex formation controls CD-NTase nucleotide selection d Nucleotide analogs reveal rules of substrate selection and product specificity d Prediction of nucleotide signal specificity in diverse CBASS anti-phage systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
27
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(28 citation statements)
references
References 31 publications
0
27
1
Order By: Relevance
“…CBASS systems show diversity in both their activation mechanisms and their cell-killing mechanisms. All CBASS systems encode an oligonucleotide cyclase related to the mammalian innate-immune sensor cGAS (cyclic GMP-AMP synthase) that synthesizes a cyclic di- or trinucleotide second messenger molecule (8,9), and a second-messenger activated effector protein that mediates cell death to abort the viral infection. Type I CBASS systems encode only these two proteins, suggesting that their cGAS-like enzyme has an innate infection-sensing capability (10).…”
Section: Introductionmentioning
confidence: 99%
“…CBASS systems show diversity in both their activation mechanisms and their cell-killing mechanisms. All CBASS systems encode an oligonucleotide cyclase related to the mammalian innate-immune sensor cGAS (cyclic GMP-AMP synthase) that synthesizes a cyclic di- or trinucleotide second messenger molecule (8,9), and a second-messenger activated effector protein that mediates cell death to abort the viral infection. Type I CBASS systems encode only these two proteins, suggesting that their cGAS-like enzyme has an innate infection-sensing capability (10).…”
Section: Introductionmentioning
confidence: 99%
“…Depletion of cellular dNTPs is a conserved antiviral strategy also found in eukaryotes, demonstrating a clear link between prokaryotic and eukaryotic immunity (20). Indeed, a striking characteristic that has emerged from recent studies is the evolutionary relatedness between many anti-phage systems and innate immune mechanisms in plants and animals (12,13,18,(21)(22)(23)(24)(25). Additional examples of bacterial anti-phage defense systems that are ancestors of eukaryotic immunity are represented by the viperins, gasdermins, NLR-related anti-phage systems, Toll/IL-1 receptor (TIR) domains (carried by the Thoeris system) and the bacterial cyclic oligonucleotide-based signalling system (CBASS) (12,13,18,(21)(22)(23)(24)(25).…”
Section: Introductionmentioning
confidence: 99%
“…However, because phages target important surface structures, such as the lipopolysaccharide (LPS) and membrane proteins as receptors, it is questionable whether mutations in receptors represent primary adaptive strategies in complex microbial communities because such modifications frequently incur fitness costs (6). Indeed, many additional defense mechanisms have recently been discovered, including CRISPR systems (14) and several other innate immunity mechanisms, many of which remain to be mechanistically characterized (15)(16)(17)(18)(19). Genes encoding both receptors and defense systems have been shown to occur frequently in variable genomic islands (6,(20)(21)(22) or to be associated with mobile genetic elements (23)(24)(25)(26).…”
mentioning
confidence: 99%